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To:      All BSAS Licensees  
 
From:  Deirdre Calvert, LICSW, Director of the Bureau of Substance Addiction Services 
 
Date:  April 3, 2020 
 
Re:      Consent for Treatment/Data Submission in BSAS-licensed/contracted Programs   
 
The purpose of this memo is to provide guidance to all programs licensed/contracted by the 
Massachusetts Department of Public Health’s (DPH) Bureau of Substance Addiction Services 
(BSAS) regarding consent requirements under 42 CFR Part 2 (Part 2) for the use and disclosure 
of Patient Identifying Information (PII). 
 
This guidance will be updated as needed and as additional information is available. Please 
regularly check mass.gov/covid19 for updated guidance as well as samhsa.gov/coronavirus. 
 
SAMHSA Guidance on Applicability of Medical Emergency Exception to Consent 
Requirements 
 
The Substance Abuse and Mental Health Services Administration (SAMHSA) has released the 
following guidance regarding the applicability of the medical emergency exception found at 42 
CFR §2.51 to situations where obtaining patient consent for use and disclose of PII is 
challenging given the current public health emergency and social distancing measures in effect.   
 
Please note that it is the responsibility of each provider to determine whether a bona fide medical 
emergency exists for purposes of providing needed treatment to patients.  
 
COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance 
 
Submission of Treatment Data to BSAS 
 
In addition to the medical emergency exception discussed above, Part 2 also permits Part 2 
programs to disclose PII to persons and organizations authorized to conduct audits and 
evaluation activities without a patient’s consent under 42 CFR §2.53  Therefore  BSAS, as the 
state’s regulating and licensing agency for substance addiction treatment services, can receive 
treatment data from addiction treatment providers without a patient’s consent.  
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 Please note that consent for disclosure of information to BSAS is separate from the consent for 
treatment described in the SAMHSA guidance, above.  
 
For the latest information, visit the DPH 2019 Novel Coronavirus website which is updated 
frequently: www.mass.gov/2019coronavirus. 
 
CDC website: https://www.cdc.gov/coronavirus/2019-ncov/index.html  
 
 
